
ONCTERNAL THERAP. O.N.
Share · US68236P2065 · ONCT · A40063 (XNCM)
No Price
n/a
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | -0,02 % | -92,94 % | -98,98 % |
Firmenprofil zu ONCTERNAL THERAP. O.N. Aktie
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.
Unternehmensdaten
Name ONCTERNAL THERAP. O.N.
Firma Oncternal Therapeutics, Inc.
Symbol ONCT
Website
https://www.oncternal.com
Heimatbörse
Frankfurt

WKN A40063
ISIN US68236P2065
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. James B. Breitmeyer M.D., Ph.D.
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 0,0 T
Adresse 12230 El Camino Real, 92130 San Diego
IPO Datum 2004-02-03
Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
10.06.2019 | GTXI | ONCT |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | ONCT |
Weitere Aktien
Investoren die ONCTERNAL THERAP. O.N. die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.